Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

National Healthcare Pptys In (NHP)

91 + Investors. Track Smart Money conviction in NHP. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%

91+

Inst. Holders

Hedge Fund Ownership: NHP

How many hedge funds hold NHP — quarterly history vs. share price
Quarterly hedge fund ownership of NHP vs. share price

Market Analysis: NHP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NHP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy National Healthcare Pptys In (NHP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NHP has moved relative to its sector benchmark (XLRE) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 45d ago
NHP
-4.1%
XLRE
+8.3%

NHP outperformed XLRE by -12.4% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 0d ago
NHP
+0.0%
XLRE
+0.0%

Since the filing became public, NHP outperformed XLRE by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 0 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
0.6
/ 10
conviction
Hedge Fund Positioning: NHP
2026 Q3 Stats Unlock in 5 days 91 + Investors

Track Smart Money conviction in NHP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 91 0 100%
13F Shares 53M 0 100%
Total Value $776M $0 100%
New Positions 91 0 +91
Increased Positions 0 0 -
Closed Positions 0 0 -
Reduced Positions 0 0 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: NHP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

91 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NHP. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 NHP holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lasalle Investment Management Securities LLC 1.87% 3,094,229 $49.6M
2 Aviso Wealth Management 0.73% 119,398 $1.9M
3 Duff & Phelps Investment Management Co 0.65% 3,942,920 $63.2M
4 Cbre Investment Management Listed Real Assets LLC 0.20% 797,921 $12.8M
5 Plotkin Financial Advisors, LLC 0.13% 20,358 $307K
6 William Blair Investment Management, LLC 0.04% 846,177 $13.6M
7 Militia Capital Management LLC 0.04% 97,168 $1.6M
8 OVERSEA-CHINESE BANKING Corp Ltd 0.03% 90,753 $1.5M
9 Principal Financial Group Inc 0.03% 3,245,065 $52.1M
10 Quantbot Technologies LP 0.02% 27,245 $437K
11 Sumitomo Mitsui Trust Group, Inc. 0.02% 1,636,170 $26.2M
12 Russell Investments Group, Ltd. 0.00% 346,477 $5.6M
13 Panagora Asset Management Inc 0.00% 100,379 $1.6M
14 Daiwa Securities Group Inc. 0.00% 138,287 $2.2M
15 Diversified Trust Co 0.00% 10,370 $166K
16 Kozak & Associates, Inc. 0.00% 1,285 $19K
17 Sei Investments Co 0.00% 207,335 $3.3M
18 Nomura Asset Management Co Ltd 0.00% 76,100 $1.2M
19 Asset Management One Co., Ltd. 0.00% 61,021 $979K
20 Copeland Capital Management, LLC 0.00% 5,619 $90K
21 Resona Asset Management Co.,Ltd. 0.00% 19,440 $315K
22 Fmr LLC 0.00% 1,836,356 $29.5M
23 Sumitomo Mitsui DS Asset Management Company, Ltd 0.00% 10,914 $175K
24 Ameritas Investment Partners, Inc. 0.00% 2,442 $39K
25 Vanguard Fiduciary Trust Co 0.00% 282,728 $4.5M
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — National Healthcare Pptys In (NHP)

Is it too late to buy National Healthcare Pptys In (NHP) following the 2026 Q3 hedge fund 13F filings?

As of today, NHP has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLRE sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), NHP has gained -4.1% vs +8.3% for XLRE. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →